(2S)-2-[[3-bromo-4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid structure
|
Common Name | (2S)-2-[[3-bromo-4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid | ||
---|---|---|---|---|
CAS Number | 13082-83-2 | Molecular Weight | 533.33500 | |
Density | 1.71g/cm3 | Boiling Point | N/A | |
Molecular Formula | C20H21BrN8O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | (2S)-2-[[3-bromo-4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid |
---|---|
Synonym | More Synonyms |
Density | 1.71g/cm3 |
---|---|
Molecular Formula | C20H21BrN8O5 |
Molecular Weight | 533.33500 |
Exact Mass | 532.08200 |
PSA | 210.54000 |
LogP | 2.58420 |
Index of Refraction | 1.746 |
Precursor 1 | |
---|---|
DownStream 1 | |
L-Glutamic acid,N-[3-bromo-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl] |
3'-Bromomethotrexate |
N-{3-Brom-4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoyl}-L-glutaminsaeure |
N-{3-bromo-4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoyl}-L-glutamic acid |
Glutamic acid,N-[3-bromo-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,L |
Monobromomethotrexate |